A detailed history of Tributary Capital Management, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Tributary Capital Management, LLC holds 2,892 shares of ZTS stock, worth $524,377. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,892
Previous 3,002 3.66%
Holding current value
$524,377
Previous $520,000 8.65%
% of portfolio
0.04%
Previous 0.04%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$172.58 - $196.48 $18,983 - $21,612
-110 Reduced 3.66%
2,892 $565,000
Q2 2024

Jul 24, 2024

SELL
$145.54 - $178.83 $18,629 - $22,890
-128 Reduced 4.09%
3,002 $520,000
Q1 2024

Apr 18, 2024

SELL
$165.67 - $199.94 $8,283 - $9,997
-50 Reduced 1.57%
3,130 $529,000
Q4 2023

Jan 16, 2024

SELL
$151.44 - $200.09 $15,144 - $20,009
-100 Reduced 3.05%
3,180 $627,000
Q2 2023

Jul 17, 2023

SELL
$160.94 - $186.23 $24,141 - $27,934
-150 Reduced 4.37%
3,280 $564,000
Q4 2022

Jan 27, 2023

SELL
$131.14 - $157.47 $9,835 - $11,810
-75 Reduced 2.14%
3,430 $503,000
Q3 2022

Oct 11, 2022

SELL
$148.29 - $182.55 $12,604 - $15,516
-85 Reduced 2.37%
3,505 $520,000
Q2 2022

Jul 19, 2022

SELL
$155.97 - $200.09 $7,798 - $10,004
-50 Reduced 1.37%
3,590 $617,000
Q1 2022

Apr 22, 2022

SELL
$181.39 - $234.03 $23,580 - $30,423
-130 Reduced 3.45%
3,640 $686,000
Q4 2021

Jan 06, 2022

SELL
$193.69 - $247.03 $28,085 - $35,819
-145 Reduced 3.7%
3,770 $920,000
Q3 2021

Oct 14, 2021

SELL
$189.29 - $209.69 $23,661 - $26,211
-125 Reduced 3.09%
3,915 $760,000
Q1 2021

Apr 20, 2021

BUY
$144.0 - $169.39 $111,600 - $131,277
775 Added 23.74%
4,040 $636,000
Q4 2020

Jan 19, 2021

SELL
$157.07 - $174.35 $141,363 - $156,915
-900 Reduced 21.61%
3,265 $540,000
Q3 2020

Oct 13, 2020

SELL
$137.1 - $165.37 $26,049 - $31,420
-190 Reduced 4.36%
4,165 $689,000
Q2 2020

Jul 20, 2020

SELL
$111.92 - $142.53 $25,182 - $32,069
-225 Reduced 4.91%
4,355 $597,000
Q1 2020

Apr 14, 2020

SELL
$92.66 - $144.94 $11,119 - $17,392
-120 Reduced 2.55%
4,580 $539,000
Q4 2019

Jan 16, 2020

SELL
$116.25 - $133.25 $11,625 - $13,325
-100 Reduced 2.08%
4,700 $622,000
Q3 2019

Oct 15, 2019

SELL
$112.57 - $128.43 $22,514 - $25,686
-200 Reduced 4.0%
4,800 $598,000
Q2 2019

Jul 11, 2019

SELL
$97.98 - $114.28 $68,586 - $79,996
-700 Reduced 12.28%
5,000 $567,000
Q1 2019

Apr 17, 2019

SELL
$81.56 - $100.67 $8,156 - $10,067
-100 Reduced 1.72%
5,700 $574,000
Q3 2018

Oct 16, 2018

SELL
$83.5 - $93.23 $1.92 Million - $2.14 Million
-23,000 Reduced 79.86%
5,800 $531,000
Q2 2018

Jul 25, 2018

SELL
$79.9 - $89.2 $806,990 - $900,920
-10,100 Reduced 25.96%
28,800 $2.45 Million
Q1 2018

Apr 19, 2018

SELL
$71.51 - $84.69 $328,946 - $389,574
-4,600 Reduced 10.57%
38,900 $3.25 Million
Q4 2017

Jan 25, 2018

SELL
$63.24 - $72.8 $208,692 - $240,240
-3,300 Reduced 7.05%
43,500 $3.13 Million
Q3 2017

Oct 19, 2017

BUY
$59.73 - $65.4 $2.8 Million - $3.06 Million
46,800
46,800 $2.98 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $84.9B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Tributary Capital Management, LLC Portfolio

Follow Tributary Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tributary Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tributary Capital Management, LLC with notifications on news.